Paisey R, Hopton M, Hartog M
Clin Endocrinol (Oxf). 1984 May;20(5):521-5. doi: 10.1111/j.1365-2265.1984.tb00099.x.
Glycosylation of human skin has been measured by an adaptation of the thiobarbituric acid reaction on samples obtained mainly at autopsy from normal and diabetic subjects. The mean (+/- 1 SD) glycosylation of skin from 33 normal subjects was 0.072 +/- 0.012 mumol fructosamine/100 mg wet weight tissue compared with 0.127 +/- 0.034 mumol (P less than 0.01) in the 10 diabetic subjects. There was a correlation between mean blood glucose levels in the 6 months before death and skin glycosylation in the diabetics, (r = 0.71, P = 0.025), but no correlation between age, sex, or the presence or absence of diabetic complications and skin glycosylation. Skin glycosylation in samples from four non diabetics was increased from 0.075 +/- 0.015 to 0.126 +/- 0.01 mumol fructosamine/100 mg wet weight tissue (P less than 0.01) after incubation with 50 mmol/l glucose solution for 7 d at 37 degrees C.
通过对主要取自正常人和糖尿病患者尸检样本的硫代巴比妥酸反应进行改良,来测定人体皮肤的糖基化情况。33名正常受试者皮肤的平均(±1标准差)糖基化为0.072±0.012微摩尔果糖胺/100毫克湿重组织,而10名糖尿病患者的这一数值为0.127±0.034微摩尔(P<0.01)。糖尿病患者死亡前6个月的平均血糖水平与皮肤糖基化之间存在相关性(r = 0.71,P = 0.025),但年龄、性别或是否存在糖尿病并发症与皮肤糖基化之间无相关性。4名非糖尿病患者样本在37℃下与50毫摩尔/升葡萄糖溶液孵育7天后,皮肤糖基化从0.075±0.015增加到0.126±0.01微摩尔果糖胺/100毫克湿重组织(P<0.01)。